🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the China Extension study is to assess the safety and effica...
Status
Completed
Location
Beijing Cancer Hospital (0601)
Start Date
2020-07-14
Trial ID
NCT04889118
Treatments Being Tested
Substudy 02B is part of a larger research study where researchers are looki...
Status
Completed
Location
The Angeles Clinic and Research Institute ( Site 2009)
Start Date
2020-07-01
Trial ID
NCT04305054
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pemetrexe...
Status
Completed
Location
Chiba University Hospital
Start Date
2022-07-01
Trial ID
NCT05258279
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Status
Unknown
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-09-01
Trial ID
NCT04127396
This will be a randomized, single-dose, open-label, two-period crossover st...
Status
Completed
Location
Charles River Clinical Studies, NW
Start Date
2010-07
Trial ID
NCT01240408
Substudy 03A is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 1008)
Start Date
2020-12-16
Trial ID
NCT04626479
This study will compare the efficacy and safety of belzutifan + lenvatinib ...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0077)
Start Date
2021-02-25
Trial ID
NCT04586231
Treatments Being Tested
Substudy 03B is part of a larger research study that is testing experimenta...
Status
Active Not Recruiting
Location
University of California at San Francisco ( Site 3008)
Start Date
2020-12-17
Trial ID
NCT04626518
Treatments Being Tested
This Expanded Access Program (EAP) consists of a Prerandomization Phase and...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02211222
Treatments Being Tested
This is a multicenter, open-label, phase Ib/II study on the efficacy and sa...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2022-05-23
Trial ID
NCT05740215
Treatments Being Tested